Literature DB >> 10079066

N-acylglycine amidation: implications for the biosynthesis of fatty acid primary amides.

B J Wilcox1, K J Ritenour-Rodgers, A S Asser, L E Baumgart, M A Baumgart, D L Boger, J L DeBlassio, M A deLong, U Glufke, M E Henz, L King, K A Merkler, J E Patterson, J J Robleski, J C Vederas, D J Merkler.   

Abstract

Bifunctional peptidylglycine alpha-amidating enzyme (alpha-AE) catalyzes the O2-dependent conversion of C-terminal glycine-extended prohormones to the active, C-terminal alpha-amidated peptide and glyoxylate. We show that alpha-AE will also catalyze the oxidative cleavage of N-acylglycines, from N-formylglycine to N-arachidonoylglycine. N-Formylglycine is the smallest amide substrate yet reported for alpha-AE. The (V/K)app for N-acylglycine amidation varies approximately 1000-fold, with the (V/K)app increasing as the acyl chain length increases. This effect is largely an effect on the KM,app; the KM,app for N-formylglycine is 23 +/- 0.88 mM, while the KM,app for N-lauroylglycine and longer chain N-acylglycines is in the range of 60-90 microM. For the amidation of N-acetylglycine, N-(tert-butoxycarbonyl)glycine, N-hexanoylglycine, and N-oleoylglycine, the rate of O2 consumption is faster than the rate of glyoxylate production. These results indicate that there must be the initial formation of an oxidized intermediate from the N-acylglycine before glyoxylate is produced. The intermediate is shown to be N-acyl-alpha-hydroxyglycine by two-dimensional 1H-13C heteronuclear multiple quantum coherence (HMQC) NMR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079066     DOI: 10.1021/bi982255j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Evidence for substrate preorganization in the peptidylglycine α-amidating monooxygenase reaction describing the contribution of ground state structure to hydrogen tunneling.

Authors:  Neil R McIntyre; Edward W Lowe; Jonathan L Belof; Milena Ivkovic; Jacob Shafer; Brian Space; David J Merkler
Journal:  J Am Chem Soc       Date:  2010-11-02       Impact factor: 15.419

Review 2.  Biosynthesis, degradation and pharmacological importance of the fatty acid amides.

Authors:  Emma K Farrell; David J Merkler
Journal:  Drug Discov Today       Date:  2008-04-03       Impact factor: 7.851

Review 3.  Fatty acid amide signaling molecules.

Authors:  Cyrine Ezzili; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

4.  Inactivation of peptidylglycine α-hydroxylating monooxygenase by cinnamic acid analogs.

Authors:  Neil R McIntyre; Edward W Lowe; Matthew R Battistini; James W Leahy; David J Merkler
Journal:  J Enzyme Inhib Med Chem       Date:  2015-05-29       Impact factor: 5.051

5.  α-Ketoheterocycle-based Inhibitors of Fatty Acid Amide Hydrolase (FAAH).

Authors:  Katerina Otrubova; Dale L Boger
Journal:  ACS Chem Neurosci       Date:  2011-12-20       Impact factor: 4.418

6.  N-acylethanolamines as novel alcohol dehydrogenase 3 substrates.

Authors:  Milena Ivkovic; Daniel R Dempsey; Sumit Handa; Joshua H Hilton; Edward W Lowe; David J Merkler
Journal:  Arch Biochem Biophys       Date:  2010-12-06       Impact factor: 4.013

7.  Primary fatty acid amide metabolism: conversion of fatty acids and an ethanolamine in N18TG2 and SCP cells.

Authors:  Emma K Farrell; Yuden Chen; Muna Barazanji; Kristen A Jeffries; Felipe Cameroamortegui; David J Merkler
Journal:  J Lipid Res       Date:  2011-11-16       Impact factor: 5.922

Review 8.  Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.

Authors:  David J Merkler; Aidan J Hawley; Betty A Eipper; Richard E Mains
Journal:  Br J Pharmacol       Date:  2022-02-28       Impact factor: 9.473

9.  Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).

Authors:  David J Merkler; Alexander S Asser; Laura E Baumgart; Natalie Carballo; Sarah E Carpenter; Geoffrey H Chew; Casey C Cosner; Jodi Dusi; Lamar C Galloway; Andrew B Lowe; Edward W Lowe; Lawrence King; Robert D Kendig; Paul C Kline; Robert Malka; Kathleen A Merkler; Neil R McIntyre; Mindy Romero; Benjamin J Wilcox; Terence C Owen
Journal:  Bioorg Med Chem       Date:  2008-10-11       Impact factor: 3.641

Review 10.  60 YEARS OF POMC: From POMC and α-MSH to PAM, molecular oxygen, copper, and vitamin C.

Authors:  Dhivya Kumar; Richard E Mains; Betty A Eipper
Journal:  J Mol Endocrinol       Date:  2015-12-14       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.